XML 44 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3 - Collaborative and Other Research and Development Contracts (Details Textual) - USD ($)
1 Months Ended 6 Months Ended 34 Months Ended
Jun. 16, 2015
Sep. 30, 2013
Jun. 30, 2006
Feb. 28, 2006
Jun. 30, 2000
Jun. 30, 2016
Jun. 30, 2016
Mar. 31, 2015
Base Contract [Member]                
Government Contract Receivable               $ 16,265,000
Additional Development Options [Member]                
Government Contract Receivable               22,855,000
ASPRBARDA Contract [Member]                
Government Contract Receivable               $ 39,120,000
Proceeds from awards for Research and Development Contracts           $ 20,574,000    
Green Cross Corporation [Member]                
Proceeds from License Fees Received     $ 250,000          
Mundipharma [Member]                
Upfront Payments Receivable Amount       $ 10,000,000        
AECOM and IRL [Member]                
Milestone Payment Maximum         $ 4,000,000      
Milestone Payment Minimum         1,400,000      
Annual License Fee Minimum         150,000      
Annual License Fee Maximum         $ 500,000      
Advance Notice Period for Termination of Agreement         60 days      
National Institute of Allergy and Infectious Diseases [Member]                
Proceeds from awards for Research and Development Contracts   $ 5,000,000       5,475,000    
Expected Receivable From Awards for Research and Development Contracts             $ 39,477,000  
Collaboration Agreement Additional Payments Received           $ 35,350 $ 35,350  
UAB [Member]                
Period of Agreement           25 years    
Renewable Period of Agreement           5 years    
CSL Limited [Member                
Proceeds from License Fees Received $ 33,740,000              
Milestone Payment Maximum $ 12,000,000              
Royalty Term 10 years